Hetenyi G Korhaz, Onkologiai Kozpont

Szolnok 5007

0 studies enrolling now · 4 studies all time

What they study most

Locally Advanced Renal Cell Carcinoma, Locally Advanced Urothelial Cancer, Metastatic Clear-Cell Renal Cell Carcinoma, Metastatic Melanoma, Metastatic Non Small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer, Metastatic Urothelial Cancer, Relapsed Small Cell Lung Cancer, Unresectable Melanoma

Studies at this site

• Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) — Completed
• Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) — Running, not enrolling
• IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18) — Running, not enrolling
• A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203) — Completed